The Dean of the University of Maryland School of Medicine, Prof Mark T. Gladwin, has praised the Institute of Human Virology Nigeria (IHVN) for its achievements in HIV prevention, treatment, and care in Nigeria.
In a message to the University of Maryland School of Medicine community, the Dean stated that he was particularly impressed with IHVN which is led by shared faculty members: Patrick Dakum, Chief Executive Officer, and Associate Professor in the Department of Epidemiology & Public Health; Charles Mensah, Chief Operating Officer; and Alash’le Abimiku, Professor in the Department of Medicine and Executive Director of the International Research Center of Excellence (IRCE).
“IHVN has partnered with the University of Maryland’s Institute of Human Virology to screen more than 8 million people in Africa. We currently have 300,000 patients on active therapy in Nigeria alone. We visited sickle cell and oncology programs and discussed how we can leverage our 25 years of partnership with Nigeria to extend our collaborations in hopes of addressing the ‘epidemics’ of non-communicable diseases, including cancer, cardiovascular disease, and sickle cell anemia,” he said.
Prof Gladwin visited Nigeria and participated in the International Research Center of Excellence (IRCE) 2nd Annual Scientific Symposium. He also visited government officials, the Hon Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, leaders of the Nigeria Sovereign Investment Authority, Lagos University Teaching Hospital, and the University of Abuja.
The Executive Director of the International Research Centre of Excellence (IRCE), Prof. Alash’le Abimiku is scheduled to participate in the Science Summit at the 79th United Nations General Assembly (UNGA 79) on 13th September 2024.
Prof Abimiku will be serving as a panelist in a session, titled “Exploring Novel Solutions for Tracking and Adapting to the Health Impacts of Climate Change in Resource-Constrained Settings” which will focus on addressing the health challenges posed by climate change, particularly in sub-Saharan Africa, and the innovative approaches required to respond to the crisis.
A press statement shared by the UNGA 79 Science Summit organizers revealed that the session will examine the critical intersections between climate change and health, with a special focus on vulnerable populations.
“Notable topics will include climate change’s effects on maternal and child health, the role of data science in monitoring, treating, and preventing health impact, and the importance of global collaboration in implementing effective national adaptation strategies,” the statement said.
“Prof Abimiku will join experts including, Anayda Portela from the World Health Organization (WHO), Brad Newsome from the National Institutes of Health (NIH), Ijeoma Solarin from Wits Planetary Health Research, and Chenfeng Xiong from Villanova University to discuss strategies for climate adaptation and financing mechanisms to support the health sector response to the Climate Crisis,” the statement said.
This session will also showcase how research, data, and international collaboration can accelerate climate action and protect the health of vulnerable communities.
In fostering an excellent work culture and staff performance, the Executive Management of the Institute of Human Virology Nigeria (IHVN) has initiated the “Employee Recognition Awards” to recognise “Employees of the Month” and “Employee of the Year.”
According to the IHVN Director of Finance and Administration, Mr. Olu Alabi, this recognition covers overall employee performance in dressing, innovation, teamwork, productivity, efficiency, leadership & interpersonal skills, punctuality and adherence to company values and principles amongst others.
For August 2024, IHVN Celebrates, Samuel Adams- Dabban, Temitope Olukomogbon, Shimang Joy, Victoria Igho Adejo, Gyang Samuel Pam, Sambo Yakubu Lodeya, Ayomide Olumefun, Omololu Ogunremi, Ibrahim Fwangmun, Frederick Saiki, Solanke Oladapo Felix, Chinye Dumebi Rosemary, Adebimpe Manuwa, Samuel Akingbesote and Adeogun Temitope, whose performance stood out in their teams.
Three hearty cheers to our August star performers!
The Dean of the University of Maryland School of Medicine, Prof Mark T. Gladwin has visited the Lagos University Teaching Hospital (LUTH) to discuss partnerships on sickle cell disease and cancer research.
During his visit, Prof. Gladwin made a seminar presentation at the Center for Clinical Trials, Research, and Implementation Science (CCTRIS) on “Pulmonary Hypertension and End-Organ Failure in Adult Patients with Sickle Cell Disease.”
He said that Nigeria has a high prevalence of sickle cell disease with “more children living with sickle cell disease than all the other countries in the world”. Prof. Gladwin called for more research into the disease, especially as people are living longer with it and might have organ complications.
The Chief Medical Director of LUTH, Prof Wasiu Adeyemo welcomed Prof. Gladwin and stated that collaboration is pivotal in building the capacity of medical practitioners in the country.
“In the next few weeks, LUTH is going to do the first transplant for sickle cell in Nigeria and definitely, that will need a lot of support from those who have the experience,” he said.
Executive Director of the University of Maryland Baltimore (UMB) Marlene and Stewart Greenbaum Comprehensive Cancer Center, Dr. Taofeek Owonikoko also made a presentation on “Building the Human Resource and Infrastructure for Oncogenic Health” during the visit.
He emphasized the need to build institution-to-institution partnerships in Nigeria and Africa to advance the management of non-communicable diseases. He revealed that there would be an 80% increase in cancer diagnosis and death between now and 2040 in Africa.
“We must do research that is problem-driven while we collaborate with colleagues who research and practice in well-resourced areas. We should not be ashamed to seek collaboration with our colleagues who operate in better-funded environments,” Dr. Owonikoko.
The visiting team also included the Associate Director of Diversity, Equity, and Inclusion at the Marlene and Stewart Greenebaum Cancer Center, Prof. Clement Adebamowo, UMB Division Head, Epidemiology and Prevention at the Institute of Human Virology, Prof. Man Charurat, Institute of Human Virology Nigeria (IHVN) Chief Executive Officer, Dr. Patrick Dakum, IHVN Chief Operating Officer and Managing Director, Dr. Charles Olalekan Mensah and Executive Director, International Research Center of Excellence (IRCE), Prof. Alash’le Abimiku.
They conducted a tour of the Lagos Teaching Hospital, Nigeria’s Sovereign Wealth Fund NSIA-LUTH Cancer Center, and facilties of the Sickle Cell Foundation Nigeria.
A cross-section of the dignitaries at Lagos University Teaching Hospital during the presentations.Seminar participants pose for a photo after the presentations by Prof Mark Gladwin and Dr. Taofeek K. Owonikoko
To enhance surveillance and response to acute febrile illness in Nigeria, the Institute of Human Virology, Nigeria (IHVN) has hosted a collaborative meeting with the Nigeria Centers for Disease Control (NCDC), US Centers for Disease Prevention and Control (CDC), representatives from the Federal and State Ministry of Health, health care workers and other stakeholders.
The two-day meeting in Abuja reviewed the progress of the Acute Febrile Illness Surveillance (AFIS) Project. The AFIS project commenced in 2022 to determine the cause of AFI among different age groups and strengthen the epidemiological and laboratory capacity of the country to address acute febrile illness.
At the meeting, the Executive Director of the International Research Center of Excellence (IRCE) Prof. Alash’le Abimiku, highlighted the essential role of collaboration in advancing Nigeria’s healthcare system. She reaffirmed the commitment of all partners to support the Nigerian government in implementation of the project as it transitions to NCDC and the State Ministry of Health for sustainability.
“One of the lessons that we have learned from the project is that we are aware of the diseases that are circulating in our population. As we survey our population, we know which region is affected so that NCDC responds to diseases in good time,”
Prof. Abimiku added that the groundwork laid through these partnerships would facilitate a smooth transition of the AFIS project. “The success of this transition—and of our broader surveillance efforts—depends on each of us,”
The AFIS Transition Workshop also featured remarks from Programme Director of the Division of Global Health Protection at the US CDC, Dr. Farah Husain who noted that the transition meeting “marks the culmination of two years of hard work and the beginning of the next phase of our partnership in this vital initiative.”
She emphasized the importance of acute febrile illness surveillance as a key component of overall public health efforts, noting that fever, a common symptom of various infections, is often misdiagnosed and incorrectly treated, contributing to drug resistance and increased morbidity and mortality.
“AFI surveillance with laboratory confirmation can help us better understand circulating pathogens and respond to emerging and re-emerging disease threats. Setting up a robust AFI surveillance system takes time, but its success will be measured by its ability to quickly detect and reduce the spread of disease within Nigeria, across its borders, and enhance global health protection.”
Director General of NCDC, Dr. Jide Idris, who was represented by the NCDC Director, Special Duties, Dr. John Oladejo said that the meeting is the beginning of a new chapter in surveillance efforts.
“This transition is not merely a handover of responsibilities but rather an opportunity to identify and address concerns, recalibrate our strategies, integrate new insights and ensure our surveillance systems are robust, responsive and adaptable to the everchanging landscape of febrile illnesses,” he said.
Executive Director of the International Research Center of Excellence (IRCE), Prof Alash’le Abimiku giving her opening remarks at the AFI meeting held in Abuja Program Director of the Division of Global Health Protection at US Centers for Disease Control (USCDC) Farah Hussain addressing the stakeholders at the meeting.
